Weis Holger 4

What Happened

• Holger Weis, a director of Jupiter Neurosciences (JUNS), recorded an exercise/conversion (Form 4 code M) on 2025-06-02 that converted 85,800 restricted stock units into 85,800 common shares. The filing shows corresponding acquisition and disposition entries at $0 — indicating the RSUs vested/converted without a cash transaction.

Key Details

• Transaction date: 2025-06-02 (reported on Form 4 filed 2026-07-13).
• Transaction type/code: M — exercise or conversion of a derivative security (RSUs).
• Shares involved: 85,800 shares converted (acquired) and 85,800 shares shown as disposed at $0 (reflecting the conversion/vesting).
• Price / value: $0 reported for the disposition; no cash proceeds were reported.
• Footnotes: F1 — RSUs convert one-for-one into common stock. F2 — the RSUs vested upon expiration of the issuer’s IPO lock-up period.
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Timeliness: The Form 4 was filed on 2026-07-13 for a 2025-06-02 transaction, indicating a late filing. Late reporting reduces timely public transparency (may have regulatory implications).

Context

• This was a conversion/vesting event (not an open‑market purchase or sale). Conversions of RSUs commonly occur when time- or event-based vesting conditions (here, IPO lock-up expiration) are met and typically involve no cash exchange. The filing does not show an immediate sale for proceeds; the $0 entries reflect the technical conversion of RSUs to common stock.